Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy

Objective To investigate the effect of hormonal androgenic treatment on antimüllerian hormone (AMH) serum levels in female-to-male (FtM) transsexuals. Polycystic ovary syndrome (PCOS) is associated with elevated AMH levels. Some hypothesize that the high AMH level is a consequence of androgen-induce...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Fertility and sterility 2015-05, Vol.103 (5), p.1340-1345
Hauptverfasser:	Caanen, Mirte R., M.D, Soleman, Remi S., M.Sc, Kuijper, Esther A.M., M.D., Ph.D, Kreukels, Baudewijntje P.C., Ph.D, De Roo, Chloë, M.D, Tilleman, Kelly, Ph.D, De Sutter, Petra, M.D., Ph.D, van Trotsenburg, Mick A.A., M.D., Ph.D, Broekmans, Frank J., M.D., Ph.D, Lambalk, Cornelis B., M.D., Ph.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Academic Medical Centers Adolescent Adult androgens Androgens - therapeutic use Anti-Mullerian Hormone - blood Antimüllerian hormone Aromatase Inhibitors - therapeutic use Biomarkers - blood Down-Regulation Female folliculogenesis Gonadotropin-Releasing Hormone - agonists Humans Internal Medicine Male Obstetrics and Gynecology Ovary - drug effects Ovary - metabolism polycystic ovary syndrome Prospective Studies Sex Reassignment Procedures - methods Tertiary Care Centers Testosterone - therapeutic use Time Factors Transsexualism - blood Transsexualism - therapy Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!